Literature DB >> 10767776

Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13.

A Tsarbopoulos1, J Varnerin, S Cannon-Carlson, D Wylie, B Pramanik, J Tang, T L Nagabhushan.   

Abstract

Interleukin 13 (IL-13), a member of the a-helical family of cytokines, has approximately 30% primary sequence homology with IL-4 and shares a common receptor component. The biologically active rhIL-13 is monomeric and non-glycosylated, and contains two disulfide bonds as determined by comparative electrospray mass spectrometric (MS) analysis of the protein before and after reduction with dithiothreitol-dithioerythritol. A trypsin-resistant core peptide of rhIL-13 was isolated and analyzed by plasma desorption (PD) MS, identifying a disulfide-linked core peptide. Subsequent digestion of this core peptide by pepsin, followed by PDMS analysis of the resulting cystine-containing peptic fragments, provided rapid determination of the existing disulfide bonds between cysteine residues 28-56 and 44-70. This disulfide arrangement is similar to that observed for the analogous four internal cysteine residues in hIL-4. The conservation of disulfide bond arrangements between hIL-13 and hIL-4, coupled with their alpha-helical structure and sequence homologies, confirms that IL-13 and IL-4 are structural homologues. It is also consistent with their reported similarities in biological function and receptor binding kinetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767776     DOI: 10.1002/(SICI)1096-9888(200003)35:3<446::AID-JMS956>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  2 in total

1.  Secondary structure and backbone resonance assignments for human interleukin-13.

Authors:  E Z Eisenmesser; D A Horita; R A Byrd
Journal:  J Biomol NMR       Date:  2001-01       Impact factor: 2.835

2.  First in-depth analysis of the novel Th2-type cytokines in salmonid fish reveals distinct patterns of expression and modulation but overlapping bioactivities.

Authors:  Tiehui Wang; Petronella Johansson; Beatriz Abós; Amy Holt; Carolina Tafalla; Youshen Jiang; Alex Wang; Qiaoqing Xu; Zhitao Qi; Wenshu Huang; Maria M Costa; Patricia Diaz-Rosales; Jason W Holland; Christopher J Secombes
Journal:  Oncotarget       Date:  2016-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.